Dr Suresh Gopala Pillai

Senior Lecturer in Emergency Medicine

Biomedical Sciences

s.k.g.pillai@swansea.ac.uk

Office (Vacant) - 005
Ground Floor
Institute of Life Science 2
Singleton Campus

Available For Postgraduate Supervision

Research Links

https://orcid.org/0000-0002-9753-6949

About

Suresh qualified in Medicine from the University of Mysore, India in 2000. He completed his specialist training in Emergency Medicine and Intensive Care Medicine from Wales Deanery. His clinical research interest is on developing biomarkers in blood coagulation utilising rheological techniques. He was awarded PhD by Swansea University on investigating the effect of chronic obstructive pulmonary disease on blood clot microstructure. Suresh was involved in the formation and the development of Welsh Centre for Emergency Medicine Research (WCEMR) that is based in Morriston Hospital Emergency Department.

Currently, Suresh is a clinical academic working as honorary consultant in Emergency Medicine (EM) and Intensive Care Medicine at Morriston Hospital, Swansea Bay University Health Board and Senior Lecturer in Emergency Medicine (Enhanced Research) at Swansea University.

Areas Of Expertise

Emergency Medicine
Intensive Care Medicine
Blood coagulation
Heamorheology
Translational research

Career Highlights

Award Highlights

2024: Royal College of Emergency Medicine (RCEM). College medal for 2024 to outstanding contribution to RCEM as Vice President, RCEM Wales.

2020: Swansea University Medical School PGR Conference. Abstract winner for 2nd year ‘Fractal Dimension as a Biomarker of Thrombogenicity in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)’

2014: All Wales School of Emergency Medicine regional meeting. First prize for poster presentation ‘Predicting outcomes after blunt chest wall trauma: development and external validation of a new prognostic model’

2011: All Wales School of Emergency Medicine regional meeting. Highly commended oral presentation of the day for case presentation- ‘SVC obstruction’.

Collaborations

Publications

Research Highlights

Evans, V., Lawrence, M., Whitley, J., Johns, C., Gopala Pillai, S., Hawkins, K., Power, K., Morris, K., Williams, R., & Evans, A. (2022). The treatment effect of rivaroxaban on clot characteristics in patients who present acutely with first time deep vein thrombosis. Clinical Hemorheology and Microcirculation, 80(2), 139-151.
https://doi.org/10.3233/ch-201030, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa56606
Lawrence, M., Evans, V., Whitley, J., Gopala Pillai, S., Williams, R., Coulson, J., Krishnan, M., Slade, P., Power, K., Morris, R., & Evans, A. (2022). The effects of apixaban on clot characteristics in atrial fibrillation: A novel pharmacodynamic biomarker. Pharmacology Research and Perspectives, 10(2)
https://doi.org/10.1002/prp2.937, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa60554
Watson, O., Gopala Pillai, S., Howard, M., Zaldua, J., Whitley, J., Burgess, B., Lawrence, M., Hawkins, K., Morris, K., & Evans, A. (2022). Impaired fibrinolysis in severe Covid-19 infection is detectable in early stages of the disease. Clinical Hemorheology and Microcirculation, 82(2), 183-191.
https://doi.org/10.3233/ch-221491, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa61002
https://pubmed.ncbi.nlm.nih.gov/35694917/
Watson, O., ZALDUA, J., Gopala Pillai, S., Whitley, J., Howard, M., Lawrence, M., Hawkins, K., Morris, K., & Evans, A. (2023). The efficacy of low molecular weight heparin is reduced in Covid-19. Clinical Hemorheology and Microcirculation, 84(3), 1-12.
https://doi.org/10.3233/ch-221635, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa63235
http://dx.doi.org/10.3233/ch-221635
Lawrence, M., Obaid, D., Sabra, A., Whitley, J., Whitley, J., Quarry, R., Gopala Pillai, S., Chase, A., Smith, D., Williams, R., Hawkins, K., Morris, R., & Evans, A. (2023). The Impact of Patient Characteristics and Antiplatelet Regimes on Clot Microstructure in Patients Treated for ST Elevation Myocardial Infarction: Clot Microstructure can Evaluate Therapeutic Efficacy. Clinical and Applied Thrombosis/Hemostasis, 29, 107602962211315
https://doi.org/10.1177/10760296221131563, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa63236
http://dx.doi.org/10.1177/10760296221131563
Gopala Pillai, S., Butcher, L., Carnicero, J., Hawkins, K., Whitley, J., Mothukuri, R., Morris, K., Erusalimsky, J., & Evans, A. (2023). The biomarkers sRAGE and df in combination are significant predictors of mortality in COVID‑19 patients. Critical Care, 27(S1), P137
https://doi.org/10.1186/s13054-023-04377-x, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65237
Gopala Pillai, S., Zaldua, J., Watson, O., Howard, M., Lawrence, M., Whitley, J., Hawkins, K., Morris, K., & Evans, A. (2023). Low FEV1 is associated with increased mortality in acute exacerbation of COPD (AECOPD) in one year. Critical Care, 27(S1)
https://doi.org/10.1186/s13054-023-04377-x, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65238
Gopala Pillai, S., Watson, O., Howard, M., Whitley, J., Hawkins, K., Morris, K., & Evans, A. (2023). Does clot microstructure (df) predict mortality in acute exacerbation of chronic obstructive pulmonary disease (AECOPD)?. Critical Care, 27(S1), 107-108.
https://doi.org/10.1186/s13054-023-04377-x, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65239
Howard, M., Watson, O., Zaldua, J., Gopala Pillai, S., Whitley, J., Lawrence, M., Hawkins, K., Guy, O., & Evans, A. (2022). NEWS2 predicts severity of underlying inflammatory response and outcome in COVID-19 patients. In Critical Care (pp. 25-26). Springer Science and Business Media LLC.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65240
http://dx.doi.org/10.1186/s13054-022-03927-z
Gopala Pillai, S., Zaldua, J., Whitley, J., Watson, O., Howard, M., Hawkins, K., Morris, K., & Evans, A. (2022). The relationship between the procalcitonin levels and clot microstructure in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Critical Care, 26(S1), 26-26.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65241
Gopala Pillai, S., Zaldua, J., Lawrence, M., Whitley, J., Watson, O., Harrison, K., Hawkins, K., Morris, K., & Evans, A. (2022). Clot microstructure (df) as a biomarker and measurement of thrombogenicity in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Critical Care, 26(S1), 28-28.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65242
Watson, O., Howard, M., Zaldua, J., Whitley, J., Gopala Pillai, S., Lawrence, M., Burgess, B., Hawkins, K., Morris, K., & Evans, A. (2022). Impaired fibrinolysis is implicated in mortality in COVID‑19 infection. In Critical Care (pp. 31-31). Springer Science and Business Media LLC.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65244
http://dx.doi.org/10.1186/s13054-022-03927-z

All Research

Journal Articles

Watson, O., ZALDUA, J., Gopala Pillai, S., Whitley, J., Howard, M., Lawrence, M., Hawkins, K., Morris, K., & Evans, A. (2023). The efficacy of low molecular weight heparin is reduced in Covid-19. Clinical Hemorheology and Microcirculation, 84(3), 1-12.
https://doi.org/10.3233/ch-221635, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa63235
http://dx.doi.org/10.3233/ch-221635
Gopala Pillai, S., Butcher, L., Carnicero, J., Hawkins, K., Whitley, J., Mothukuri, R., Morris, K., Erusalimsky, J., & Evans, A. (2023). The biomarkers sRAGE and df in combination are significant predictors of mortality in COVID‑19 patients. Critical Care, 27(S1), P137
https://doi.org/10.1186/s13054-023-04377-x, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65237
Gopala Pillai, S., Zaldua, J., Watson, O., Howard, M., Lawrence, M., Whitley, J., Hawkins, K., Morris, K., & Evans, A. (2023). Low FEV1 is associated with increased mortality in acute exacerbation of COPD (AECOPD) in one year. Critical Care, 27(S1)
https://doi.org/10.1186/s13054-023-04377-x, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65238
Gopala Pillai, S., Watson, O., Howard, M., Whitley, J., Hawkins, K., Morris, K., & Evans, A. (2023). Does clot microstructure (df) predict mortality in acute exacerbation of chronic obstructive pulmonary disease (AECOPD)?. Critical Care, 27(S1), 107-108.
https://doi.org/10.1186/s13054-023-04377-x, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65239
Lawrence, M., Obaid, D., Sabra, A., Whitley, J., Whitley, J., Quarry, R., Gopala Pillai, S., Chase, A., Smith, D., Williams, R., Hawkins, K., Morris, R., & Evans, A. (2023). The Impact of Patient Characteristics and Antiplatelet Regimes on Clot Microstructure in Patients Treated for ST Elevation Myocardial Infarction: Clot Microstructure can Evaluate Therapeutic Efficacy. Clinical and Applied Thrombosis/Hemostasis, 29, 107602962211315
https://doi.org/10.1177/10760296221131563, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa63236
http://dx.doi.org/10.1177/10760296221131563
Watson, O., Gopala Pillai, S., Howard, M., Zaldua, J., Whitley, J., Burgess, B., Lawrence, M., Hawkins, K., Morris, K., & Evans, A. (2022). Impaired fibrinolysis in severe Covid-19 infection is detectable in early stages of the disease. Clinical Hemorheology and Microcirculation, 82(2), 183-191.
https://doi.org/10.3233/ch-221491, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa61002
https://pubmed.ncbi.nlm.nih.gov/35694917/
Lawrence, M., Evans, V., Whitley, J., Gopala Pillai, S., Williams, R., Coulson, J., Krishnan, M., Slade, P., Power, K., Morris, R., & Evans, A. (2022). The effects of apixaban on clot characteristics in atrial fibrillation: A novel pharmacodynamic biomarker. Pharmacology Research and Perspectives, 10(2)
https://doi.org/10.1002/prp2.937, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa60554
Gopala Pillai, S., Zaldua, J., Whitley, J., Watson, O., Howard, M., Hawkins, K., Morris, K., & Evans, A. (2022). The relationship between the procalcitonin levels and clot microstructure in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Critical Care, 26(S1), 26-26.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65241
Gopala Pillai, S., Zaldua, J., Lawrence, M., Whitley, J., Watson, O., Harrison, K., Hawkins, K., Morris, K., & Evans, A. (2022). Clot microstructure (df) as a biomarker and measurement of thrombogenicity in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Critical Care, 26(S1), 28-28.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65242
Evans, V., Lawrence, M., Whitley, J., Johns, C., Gopala Pillai, S., Hawkins, K., Power, K., Morris, K., Williams, R., & Evans, A. (2022). The treatment effect of rivaroxaban on clot characteristics in patients who present acutely with first time deep vein thrombosis. Clinical Hemorheology and Microcirculation, 80(2), 139-151.
https://doi.org/10.3233/ch-201030, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa56606

Conference Contributions

Howard, M., Watson, O., Zaldua, J., Gopala Pillai, S., Whitley, J., Lawrence, M., Hawkins, K., Guy, O., & Evans, A. (2022). NEWS2 predicts severity of underlying inflammatory response and outcome in COVID-19 patients. In Critical Care (pp. 25-26). Springer Science and Business Media LLC.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65240
http://dx.doi.org/10.1186/s13054-022-03927-z
Watson, O., Howard, M., Zaldua, J., Whitley, J., Gopala Pillai, S., Lawrence, M., Burgess, B., Hawkins, K., Morris, K., & Evans, A. (2022). Impaired fibrinolysis is implicated in mortality in COVID‑19 infection. In Critical Care (pp. 31-31). Springer Science and Business Media LLC.
https://doi.org/10.1186/s13054-022-03927-z, SU Repository: https://cronfa.swan.ac.uk/Record/cronfa65244
http://dx.doi.org/10.1186/s13054-022-03927-z